• Rate of long-term follow-up reporting
• Physician attendance at regional quality group meetings
• Quality improvement activities
• Number of VQI registries subscribed , which provides opportunities for learning and improvement
45
Centers are eligible to receive up to three stars depending on the extent of their participation in four categories :
• Rate of long-term follow-up reporting
• Physician attendance at regional quality group meetings
• Quality improvement activities
• Number of VQI registries subscribed , which provides opportunities for learning and improvement
* Per VQI : This award does not represent the quality of care delivered but rather is a measurement of VQI participation .
Outcomes published in the most recent regional quality report for calendar year 2023 procedures included the following results indicating the hospital performed better than the expected rate and the region ’ s observed rates :
VQI Overall
Region
BSWHVH
TCAR symptomatic stroke / death in hospital 2.2 % 1.8 % 0.0 % Carotid endarterectomy symptomatic : stroke / death in hospital 1.8 % 1.4 % 0.0 %
Transfemoral carotid artery stent symptomatic : stroke / death in hospital
Transfemoral carotid artery stent asymptomatic : stroke / death in hospital
4.0 % 2.6 % 0.0 %
1.9 % 2.7 % 0.0 %
Procedures performed between January 1 , 2023 and December 31 , 2023 at Baylor Scott & White Heart and Vascular Hospital - Dallas ( BSWHVH ).
Each year , the Society for Vascular Surgery invites participants to submit abstracts for poster presentations focused on quality improvement . Manager of Clinical Performance Measures , Priya Padmanabhan , MHA , LSSYB , presented her poster “ Coordinating a shared decision-making initiative ” at the national Vascular Annual Meeting , June 2024 , in Chicago , Illinois .
Aortic Center ’ s multidisciplinary approach
A multidisciplinary approach is taken in the treatment and care of patients with aortic disease . With the help of a nurse navigator , patients referred to the center benefit from collaboration of vascular surgeons and cardiothoracic surgeons on the medical staff . Weekly case reviews occur . Known for their clinical expertise in abdominal aortic aneurysms and recognized by U . S . News & World Report with a High Performing rating in 2024-2025 , the team treats complex aortic arch dissection , as well as aortic aneurysms . The team also works closely with organizations who are involved in research regarding the familial connection for those who experience aortic disease conditions .
Better Than Expected
Vascular surgeons team with heart failure specialists
Barostim™ Baroreflex Activation Therapy is currently the world ’ s first and only FDA-approved heart failure device to use neuromodulation — the power of the brain and nervous system — to improve the symptoms of patients with systolic heart failure . This therapy was designed to treat heart failure patients who may not be receiving adequate symptom relief from medications alone . This procedure is achieved through close collaboration of the patient ’ s advanced heart failure specialist and the vascular surgeon on the hospital ’ s medical staff who completes the surgical implant .
Unlike other heart failure device therapies , Barostim contains no hardware in the heart or vasculature . It works by electrically stimulating baroreceptors — natural sensors located in the wall of the carotid artery — that tell the nervous system how to regulate heart , kidney and vascular function . These effects reduce the heart ’ s workload and help it pump more efficiently , restoring balance to the autonomic nervous system and improving the symptoms of heart failure . Barostim plus heart failure medications has been shown to improve exercise capacity , quality of life and NYHA class , helping patients return to their daily activities .
Baylor Scott & White Heart and Vascular Hospital — Dallas | Vascular Surgery
For more information about the Dallas Aortic Center , see the Advanced Cardiovascular Centers section in this book . Referrals can be made by calling 214.820.4876 .